Interlaboratory Oral Anticoagulant Quality Assessment by the Netherlands Federation of Thrombosis Services

Summary

The 50 laboratories of the Netherlands Federation of Thrombosis Services, covering a population of 9 million and responsible for the laboratory control of approximately 150,000 patients under oral anticoagulation, have participated since 1974 in a voluntary external and internal quality control program. The external program comprises a monthly distribution to the member laboratories of a series of artificially prepared control blood samples, two of which are identical. The overall variation of the coagulation times found were 10% (CV) in 1974 and 8% (CV) in 1975. Performance improved rather abruptly at the beginning of 1975, after the application of a tight methodological standardization and improvement by the manufacturer of the thromboplastin preparation (Thrombotest) used by the great majority of the laboratories involved. The main source of variation was found to be random error in the Thrombotest determination, approximating 6%. Interbatch variation of Thrombotest and inter-aliquot variation of control blood samples both do amount to approximately 3% (CV). In terms of rabbit tissue thromboplastins, which have a lower sensitivity than Thrombotest (i. e., a flatter slope of the correlation between the PT and the anticoagulant effect), the total variation in the performance of the Dutch laboratories is 2.2-5.6% (CV), which is unusually low. The main reason for this is the fact that the laboratories can rely not only on the services of the manufacturer but also on a central information office and a reference laboratory responsible for the preparation of the control blood as well as the standardization (calibration) of thromboplastin.

• References

• 1 Beeser H, Merten R, Drescher H, Fischer J. A German prothrombin time proficiency testing program. Thrombosis et Diathesis Haemorrhagica 1975; 33: 152
• 2 Biggs R, Denson K. W. E. Standardization of the onestage prothrombin time for the control of anticoagulant therapy. British Medical Journal 1967; 1: 84
• 3 Dijk-Wierda C. A. van (submitted for publication): The preparation of control blood for external quality assessment of the prothrombin time. Thrombosis and Haemostasis.;
• 4 Eilers R. J. Principles of total quality control. In: Lewis, S. M. and Coster, J. F. (ed.), Quality Control in Haematology. Symposion of the International Committee for Standardization in Haematolo-gy. Academic Press; London, New York, San Francisco: 1975: 1
• 5 Goguel A. Interlaboratory trials. Surveys in France. In Lewis S. M, Coster J. F. (ed.), Quality Control in Haematology. Symposion of the International Committee for Standardization in Haematology. Academic Press; London, New York, San Francisco: 1975: 69
• 6 Goguel A. Contrôle de qualité du temps de Quick. Renseignements fournis par les confrontations interlaboratoires “Etalonorme” 1973 à 1976: 1975
• 7 Grimmer Ø. Personal communication.
• 8 Jordan F. L. J. Organization of the “Thrombosis Service” in the Netherlands. Thrombosis et Diathesis Haemorrhagica 1958; 2: 527
• 9 Koepke J. A. The 1969 survey of prothrombin time. American Journal of Clinical Pathology 1970; 54: 502
• 10 Koepke J. A. Interlaboratory trials: the quality control survey program of the College of American Pathologists. In Lewis S. M, Coster J. F. (ed.), Quality Control in Haematology. Symposion of the International Committee for Standardization in Haematology. Academic Press; London, New York, San Francisco: 1975: 59
• 11 Leck I, Thomson J. M, Poller L. Quality control trials in the national reference thromboplastin scheme. British Journal of Haematology 1973; 25: 453
• 12 Leck I, Gowland E, Poller L. The variability of measurements of the prothrombin time ratio in the national quality control trials. A follow-up study. British Journal of Haematology 1974; 28: 601
• 13 Loeliger E. A, Halem-Visser L. P. van. A simplified thromboplastin calibration procedure for standardization of oral anticoagulant control. Thrombosis et Diathesis Haemorrhagica 1975; 33: 172
• 14 Loeliger E. A. et al. Thromboplastin calibration. Experience of the Dutch Reference Laboratory for Anticoagulant Control. In preparation.
• 15 Loeliger E. A. Personal experience.
• 16 Miale J. B, Lafond D. J. 1963 Prothrombin time test survey. College of American Pathologists Standards Committee, Subcommittee on Coagulation. American Journal of Clinical Pathology 1967; 47: 40
• 17 Murphy E. A, Denson K. W. E. Statistical analysis of experiments performed in connection with thromboplastin standardization. Thrombosis et Diathesis Haemorrhagica, Suppl 1970; 39: 377
• 18 Owren P. A. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959; 11: 754
• 19 Poller L. The British system for anticoagulant control. Thrombosis et Diathesis Haemorrhagica 1975; 33: 157
• 20 Schmidt R. M, Eilers R. J. Prothrombin time proficiency testing in the United States. Thrombosis et Diathesis Haemorrhagica 1975; 33: 148
• 21 Whitehead T. P. Personal communication.
• 22 Zucker S, Brosious E, Cooper G. R. One-stage prothrombin time survey. American Journal of Clinical Pathology 1970; 53: 340